HomeONCT • NASDAQ
add
Oncternal Therapeutics Inc
Previous close
$9.41
Day range
$9.27 - $9.27
Year range
$5.57 - $13.14
Market cap
27.44M USD
Avg Volume
4.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 569.00K | 180.30% |
Operating expense | 3.29M | -0.78% |
Net income | -8.39M | 26.98% |
Net profit margin | -1.47K | 73.95% |
Earnings per share | -2.83 | 29.25% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 34.26M | -36.94% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 30.05M | — |
Shares outstanding | 2.96M | — |
Price to book | 0.92 | — |
Return on assets | — | — |
Return on capital | -72.27% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -8.39M | 26.98% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1997
Website
Employees
29